Transcatheter aortic valve implantation TAVI as a clinical interventional therapy, provides an ideal alternative treatment for critically ill patients with aortic stenosis who can not tolerate valve replacement through surgical means. VitaFlow Liberty features retrievability and repositioning, enabling deployment and retrieval of the valve in a stable, accurate and fast manner, which will better benefit the patients. At present, it is the only motorized retrievable system in the world

Before the world even imagined that 4 million drug-eluting stents would be available in 36 countries around the world, the founders of MicroPort® were imagining how they would impact the lives of people through technology. Their belief was that these medical technologies must be accessible to everyone. Relentless innovation has inspired promising product development and initiated strategic investments in emerging scientific platforms. Today, we see a promising path forward, one that addresses the most challenging healthcare issues, while allowing us to explore the ways to accelerate and broaden access to medical technology innovation.

MicroPort CardioFlow adheres to the vision of building a people centric enterprise ranking as a global leader of evolving and emerging medical technologies